Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
Mai Tanaka et al.
CANCERS (2020)
Gas6 expression is reduced in advanced breast cancers
Ayman M. Ibrahim et al.
NPJ PRECISION ONCOLOGY (2020)
Axl signaling is an important mediator of tumor angiogenesis
Mai Tanaka et al.
Oncotarget (2019)
S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma
Yiren Xiao et al.
CANCER RESEARCH (2019)
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Xiangyu Zhang
CANCER COMMUNICATIONS (2019)
Stromal Gas6 promotes the progression of premalignant mammary cells
Angelica M. Gomes et al.
ONCOGENE (2019)
Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib
Luis Eduardo Zucca et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
Wilhem Leconet et al.
CLINICAL CANCER RESEARCH (2017)
The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
Diana J. Uribe et al.
PLOS ONE (2017)
Macrophages promote the progression of premalignant mammary lesions to invasive cancer
Emily C. Carron et al.
ONCOTARGET (2017)
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
Pinar Kanlikilicer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
Jawed Akhtar Siddiqui et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H. Myers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma
Min-Shu Hsieh et al.
ONCOTARGET (2016)
The Receptor Tyrosine Kinase AXL in Cancer Progression
Erinn B. Rankin et al.
CANCERS (2016)
Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma
H. Yu et al.
BRITISH JOURNAL OF CANCER (2015)
MMP-9 expression varies according to molecular subtypes of breast cancer
Einas M. Yousef et al.
BMC CANCER (2014)
Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
W. Leconet et al.
ONCOGENE (2014)
AXL kinase as a novel target for cancer therapy
Xiaoliang Wu et al.
ONCOTARGET (2014)
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
Christine Mehner et al.
ONCOTARGET (2014)
KNOCKDOWN OF AXL RECEPTOR TYROSINE KINASE IN OSTEOSARCOMA CELLS LEADS TO DECREASED PROLIFERATION AND INCREASED APOPTOSIS
Y. Zhang et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2013)
Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines
A. N. Rettew et al.
ONCOGENESIS (2012)
Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma
Xianzhou Song et al.
CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer
Giridhar Mudduluru et al.
MOLECULAR CANCER RESEARCH (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
Yusuke Shiozawa et al.
NEOPLASIA (2010)
MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner
Kana Miyamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target
Jan-Bart M. Koorstra et al.
CANCER BIOLOGY & THERAPY (2009)
Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival
Anna Gustafsson et al.
CLINICAL CANCER RESEARCH (2009)
Biology of breast cancer bone metastasis
Mojtaba Akhtari et al.
CANCER BIOLOGY & THERAPY (2008)
Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer et al.
CLINICAL CANCER RESEARCH (2008)
Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
K-Y Tai et al.
ONCOGENE (2008)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
RANKL-RANK signaling in osteoclastogenesis and bone disease
T Wada et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Expression of Axl in lung adenocarcinoma and correlation with tumor progression
YS Shieh et al.
NEOPLASIA (2005)
Multiple roles for the receptor tyrosine kinase Axl in tumor formation
SJ Holland et al.
CANCER RESEARCH (2005)
Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer
C Müller-Tidow et al.
CANCER RESEARCH (2005)
Tumour-cell invasion and migration: Diversity and escape mechanisms
P Friedl et al.
NATURE REVIEWS CANCER (2003)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Share Paper
